Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal
Konstantin Zedtwitz-Liebenstein1, Christoph Wenisch, Sandra Patruta
1Division of Infectious Diseases, Department of Internal Medicine I, University Hospital, Vienna, Austria.
Objective:
Neutrophils play a crucial role in host defense against infectious disease. The objective was to analyze the effect of omeprazole treatment on indexes of neutrophil function in healthy subjects.
Design:
Open.
Setting:
University hospital.
Subjects:
Ten healthy subjects.
Intervention:
Analysis of blood samples before and after omeprazole administration.
Measurements And Main Results:
Neutrophil Escherichia coli phagocytosis was assessed by microscopy and flow cytometry. Intracellular production of reactive oxygen intermediates was measured by flow cytometry. Extracellular reactive oxygen intermediate production was assessed with a cytochrome c reduction assay. Neutrophil bactericidal capacity and intracellular concentrations of Ca2+ were determined by fluorometry. Four hours after a single 40-mg dose of omeprazole, intra- and extracellular reactive oxygen intermediate production by neutrophils was significantly reduced compared with pretreatment values: -30% (24% to 42%) (median and range) and -22% (21% to 68%; p <.05 for both). The intracellular Ca2+ concentrations in resting neutrophils were significantly increased (+33%, 21% to 39%, compared with pretreatment concentrations, p <.001) and neutrophilic bactericidal activity was decreased (-30%, 19% to 47%, compared with pretreatment concentrations, p <.0001). Intracellular Ca2+ concentrations correlated with intracellular reactive oxygen intermediate production and neutrophilic bactericidal capacity (r =.730 and r =.618, p <.05 for both, respectively). In contrast, phagocytosis rates were not impaired by omeprazole.
Conclusions:
Our results imply that omeprazole impairs production of reactive oxygen intermediates by neutrophils. Whether specific impairments of neutrophil host defenses occur in vivo remains uncertain. Reduced bactericidal activity is associated with an increase of intracellular Ca2+ concentrations in resting neutrophils.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease II: Pathophysiology
